Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neth Heart J. 2012 Apr;20(4):176-8. doi: 10.1007/s12471-012-0250-5.

Antithrombotic therapy in heart failure.

Author information

  • 1Department of Cardiology, Onze Lieve Vrouwe Gasthuis (OLVG), Oosterpark 9, 1091 AC, Amsterdam, the Netherlands, f.w.a.verheugt@olvg.nl.

Abstract

Patients with congestive heart failure have a significant risk of stroke due to thromboembolism from the dilated left ventricle. Two relatively small trials suggest that oral anticoagulation with vitamin-K antagonists may reduce this risk when compared with placebo, aspirin or clopidogrel. However, more studies are eagerly awaited. So far, physicians seeing patients with heart failure should decide who needs antithrombotic prophylaxis on a case-by-case basis, especially since most heart failure patients have significant comorbidity precluding the use of oral anticoagulant.

PMID:
22322584
[PubMed]
PMCID:
PMC3303021
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk